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Abstract: Environmental factors have been linked to many diseases and health conditions, but reliable
assessment of environmental exposures is challenging. Developing biomarkers of environmental
exposures, rather than relying on self-report, will improve our ability to assess the association
of such exposures with disease. Epigenetic markers, most notably DNA methylation, have been
identified for some environmental exposures, but identification of markers for additional exposures
is still needed. The rationale behind the Markers for Environmental Exposures (MEE) Study was to
(1) identify biomarkers, especially epigenetic markers, of environmental exposures, such as pesticides,
air/food/water contaminants, and industrial chemicals that are commonly encountered in the general
population; and (2) support the study of potential relationships between environmental exposures
and health and health-related factors. The MEE Study is a cross-sectional study with potential for
record linkage and follow-up. The well-characterized cohort of 400 postmenopausal women has
generated a repository of biospecimens, including blood, urine, and saliva samples. Paired data
include an environmental exposures questionnaire, a breast health questionnaire, dietary recalls,
and a food frequency questionnaire. This work describes the rationale, study design, and cohort
characteristics of the MEE Study. In addition to our primary research goals, we hope that the data and
biorepository generated by this study will serve as a resource for future studies and collaboration.
Keywords: environmental exposures; biomarker; DNA methylation; epigenetics; biorepository
1. Introduction
Studies suggest that human cancers are due to a combination of factors, including heredity, random
mutations, and environmental factors [1–5]. In addition, environmental factors, including exposure to
tobacco smoke, alcohol consumption, obesity, inadequate physical activity, radiation, and chemical
exposures, have been shown to be associated with many other major chronic diseases, including
cardiovascular disease [6], stroke [7], chronic obstructive pulmonary disease [8], and diabetes [9] as
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well as other conditions ranging from infertility to neurodegenerative diseases [10,11]. While some of
these factors are well-established risk factors for disease, the evidence for many others is insufficient.
Reliable estimates of exposure are needed to analyze the potential relationships between exposures
and health. Self-reporting is commonly used to assess environmental exposures in epidemiological
research. However, compared to direct measurements, such as biomarker measurement, self-reported
data are prone to recall bias, conscious or unconscious. For example, studies have found that about 20%
of pregnant women with cotinine levels indicative of current smoking failed to report their smoking
habits when asked [12,13]. For many other environmental exposures, self-report is difficult because
individuals may be unaware of the dose, frequency, or time frame of exposure. Biomarkers can serve
as objective markers for environmental exposures which may be used to improve our understanding
of how exposures relate to health.
In recent years, interest has mounted in identifying epigenetic markers for exposures, or markers
based on differences in non-sequence modifications of the DNA [14–16]. DNA methylation is
the best-studied epigenetic mechanism in this area and has several properties that make it ideal for
marker development. First, it has a desirable balance between plasticity (allowing a biologic response
to environmental insults) and long-term stability (allowing the assessment of past exposures). This
has allowed the identification of DNA methylation-based biomarkers of numerous environmental
exposures, most notably cigarette smoking, which has been consistently associated with methylation
at sites within the AHRR and F2RL3 genes in numerous studies [17–19]. In one study, AHRR
methylation predicted current smoking status with an area under the curve (AUC) of 0.99 [20].
Studies of smoking have also demonstrated the long-term stability of DNA methylation biomarkers,
with one study showing that former smokers exhibit an intermediate methylation status and may
return to a “nonsmoking” state over a period of at least 10 years [21]. Another useful quality is that
DNA methylation can be relatively easily measured from blood, saliva, or tissue DNA, including
banked DNA, which will allow leveraging of existing large cohort studies and biorepositories in
order to identify associations of environmental exposures with health outcomes. Specific patterns
of DNA methylation have been identified for some other environmental exposures, including air
pollution [22,23] and polycyclic aromatic hydrocarbons [24,25], but the impact of many environmental
exposures on the epigenome remains unknown.
This paper describes the design, methods, and participants of the Markers for Environmental
Exposures (MEE) Study, a cross-sectional study conducted from 2017–2019 comprised of
400 postmenopausal women aged 45 to 66 years in Southern California. Questionnaire data, medical
record data, and biospecimens were collected from each participant. The repository of data and
biospecimens (and molecular profiles obtained from them) can be linked to future cancer registry data
and other publicly available data (Figure 1). This conceptual framework will support the long-term
vision of the MEE Study to (1) identify biomarkers, especially epigenetic markers, of environmental
exposures, such as pesticides, air/food/water contaminants, and industrial chemicals that are commonly
encountered in the general population; and (2) support the study of potential relationships between
environmental exposures and health and health-related factors.
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Figure 1. Conceptual model for the MEE Study. The conceptual model includes both completed and 
potential (future) data collection. At the time of this writing, completed collections include all listed 
questionnaire-based data, biospecimens, epigenomic profile, urinary levels of glyphosate, 
organophosphate pesticides, and bisphenols A and S, and mammogram reports. 
2. Materials and Methods  
2.1. Study Design 
The MEE Study is a cross-sectional study with potential for follow-up data collection and 
linkage. The study was approved by the University of California, Irvine (UCI) Institutional Review 
Board (HS# 2016-3127), and the investigators worked closely with a panel of three patient and 
research advocates from the community (S.B., D.H., and V.L.). While the study was originally 
designed with the intention of identifying epigenetic markers for pesticide exposure and factors 
related to breast cancer risk, the data and specimens collected can potentially be used in the context 
of other diseases, conditions, and environmental exposures. All participants provided written 
consent to participate in the study and HIPAA authorization. 
The study workflow is outlined in Figure 2. Participants were asked to complete six online 
questionnaires, provide biospecimens, and provide authorization to access their breast health-related 
medical records (Table 1). The six questionnaires consisted of an environmental exposures 
questionnaire, a breast health questionnaire, three 24-h dietary recalls completed on three separate 
days (two weekdays and one weekend day), and a food frequency questionnaire. The biospecimens 
consisted of two self-collected first-void urine samples, a venous peripheral blood sample, and an 
optional saliva sample. Study participants received a nutrition report based on their 24-h dietary 
recalls and a report of their urinary levels of certain pesticides (glyphosate and organophosphates); 
participants received no monetary compensation. 
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2. Materials and Methods
2.1. Study Design
The MEE Study is a cross-sectional study with potential for follow-up data collection and linkage.
The study was approved by the University of California, Irvine (UCI) Institutional Review Board
(HS# 2016-3127), and the investigators worked closely with a panel of three patient and research
advocates from the community (S.B., D.H., and V.L.). While the study was originally designed with
the intention of identifying epigenetic markers for pesticide exposure and factors related to breast
cancer risk, the data and specimens collected can potentially be used in the context of other diseases,
conditions, and environmental exposures. All participants provided written consent to participate in
the study and HIPAA authorization.
The study workflow is outlined in Figure 2. Participants were asked to complete six online
questionnaires, provide biospecimens, and provide authorization to access their breast health-related
medical records (Table 1). The six questionnaires consisted of an environmental exposures questionnaire,
a breast health questionnaire, three 24-h dietary recalls completed on three separate days (two weekdays
and one weekend day), and a food frequency questionnaire. The biospecimens consisted of two
self-collected first-void urine samples, a venous peripheral blood sample, and an optional saliva
sample. Study participants received a nutrition report based on their 24-h dietary recalls and a report
of their urinary levels of certain pesticides (glyphosate and organophosphates); participants received
no monetary compensation.
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Figure 2. Study workflow. The MEE Study collected biospecimens and questionnaire-based data from 
400 postmenopausal women aged 45 to 66 years residing in Southern California. 
Table 1. Data and specimens collected. 
Data Sources Description 
Environmental exposures 
questionnaire 
Environmental exposures, source of drinking water, organic eating 
behaviors, residence history, occupation 
Breast health questionnaire Personal medical history, reproductive history, family history of cancer, 
demographic data 
Dietary recalls (ASA24) Complete report of all food, drink, and supplements consumed the 
previous day (3 recalls were requested) 
Food frequency questionnaire 
(DHQII) 
Summary of dietary intake frequencies over the previous year 
Electronic medical record Mammogram reports 
Specimens Collected Description 
Blood Peripheral blood, separated into serum, plasma, and buffy coat; DNA 
extracted from buffy coat 
Urine Two first-void urine samples 
Saliva Optional saliva sample 
2.2. Study Population 
Four hundred (400) participants were recruited from October 2017 to May 2019. Participants 
were female residents of primarily Orange County, CA. Women were eligible to participate in the 
study if they were aged 45–66 years, postmenopausal (had not had their period in over one year), 
and had never been diagnosed with breast cancer or had a mastectomy. Eligibility criteria were based 
Figure 2. Study workflow. The M E Study collected biospecimens and questio naire-based data from
4 0 postmenopausal women aged 45 to 6 years residing in Southern California.
Table 1. Data and specimens collected.
Data Sources Description
E vironmental exposures
questionnaire
Environmental exposures, source of drinking organic
eating behaviors, residence hist ry, occupation
Breast health questionnaire Personal medical history, reproductive history, family history of
cancer, demographic data
Dietary recalls (ASA24) Complete report of all food, drink, and supplements consumed
the previous day (3 recalls were requested)
Food frequency questionnaire
(DHQII)
Summary of dietary intake frequencies over the previous year
Electronic medical record Mammogram reports
Specimens Collected Description
Blood Peripheral blood, separated into serum, plasma, and buffy coat;
DNA extracted from buffy coat
Urine Two first-void urine samples
Saliva Optional saliva sample
2.2. Study Population
Four hundred (400) participants were recruited from October 2017 to May 2019. Participants were
female residents of primarily Orange County, CA. Women were eligible to participate in the study if
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they were aged 45–66 years, postmenopausal (had not had their period in over one year), and had
never been diagnosed with breast cancer or had a mastectomy. Eligibility criteria were based on
the study’s main aim of identifying epigenetic markers for pesticide exposure and factors related to
breast cancer risk. Age is known to be associated with epigenetic changes [26,27] as well as breast
cancer risk [28], and menopause has also been shown to be associated with epigenetic changes [29].
Women with a personal history of breast cancer or mastectomy were excluded in order to capture
the population at risk for incident breast cancer.
There were two primary methods of study recruitment (Figure 3). The first involved personal
mailings to patients who had received a screening mammogram at a University of California, Irvine
Health facility and had consented to be contacted for future research studies as part of the Athena
Breast Health Network [30]. For women who were eligible based on their most recent breast health
questionnaire, three attempts were made to contact them using varied methods (telephone, mail, and
email). Participants were also recruited from the broader community through email announcements to
UCI employees; announcements/flyers posted on social media, local community boards, and at events;
and via word-of-mouth. This method relied on potential participants initiating contact with the study
team after seeing the announcement or flyer. Translated materials were available for patients whose
primary language was Spanish. The study coordinator was fluent in both English and Spanish.
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2.3. Specimen and Data Collection 
2.3.1. Specimen Collection, Processing, and Storage 
After enrolling in the study and scheduling a blood collection appointment, participants were 
mailed study materials including printed instructions in English or Spanish and two sterile urine 
collection cups labeled with their study ID. The 4-oz (118 mL) collection cups were individually 
sealed, made of high-density polyethylene plastic and had a spill-proof, leak-resistant screw-on 
sealing cap. A security seal on the cap prevented any tampering. Participants were advised that 
during the 10-day period prior to their scheduled blood collection appointment, they would be 
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2.3. Specimen and Data Collection
2.3.1. Specimen Collection, Processing, and Storage
After enrolling in the study and scheduling a blood collection appointment, participants were
mailed study materials including printed instructions in English or Spanish and two sterile urine
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collection cups labeled with their study ID. The 4-oz (118 mL) collection cups were individually sealed,
made of high-density polyethylene plastic and had a spill-proof, leak-resistant screw-on sealing cap.
A security seal on the cap prevented any tampering. Participants were advised that during the 10-day
period prior to their scheduled blood collection appointment, they would be contacted on two separate
days at 7:30 PM to ask them to self-collect their first-void urine samples the following morning and
place the filled collection cups in a freezer (−20 ◦C) until their appointment. Contact was via text
message or email based on participant preference. Participants were not told which days they would
be contacted, ensuring capture of their typical behaviors and exposures.
Peripheral blood was collected at the participant’s home or other location of the participant’s
choice by the study coordinator, who was also a certified phlebotomist. Three glass Vacutainer® blood
collection tubes were used: one containing ethylenediaminetetraacetic acid (EDTA), one containing
acid citrate dextrose (ACD), and one with no anticoagulants. Blood tubes were wrapped in an insulated
bag and placed in a portable cooler with ice so the samples were cold but did not reach the point
of freezing, while the coordinator was in the field. At the time of the blood collection appointment,
the study coordinator also collected the previously frozen urine samples and placed them in the portable
cooler. Upon arrival at the lab, the urine samples were stored at 4 ◦C to thaw overnight; the next day,
the samples were aliquoted and stored at −80 ◦C for future analysis.
Within six hours of blood collection, blood samples were centrifuged at 2000 rpm for 10 min and
isolated for serum (from tube with no anticoagulant), plasma (from EDTA and ACD tubes, separately)
and buffy coat (from EDTA and ACD tubes, pooled). The serum and plasma were divided into 2 mL
aliquots and stored at −80 ◦C for future use. DNA was extracted from the buffy coat using the QIAamp
DNA Blood Maxi Kit (Cat No. 51194, QIAGEN, Hilden, Germany). Extracted DNA was quantitated
using the Qubit™ dsDNA HS Assay (Cat No. Q32854, ThermoFisher Scientific, Waltham, MA, USA)
and the BioTek Synergy HT (BioTek, Winooski, VT, USA) microplate reader, and stored at −80 ◦C.
Optional saliva samples were collected from the participants in 15 mL Falcon tubes and stored at
−80 ◦C for future analysis.
2.3.2. Environmental Exposures and Breast Health Data Collection
Data on environmental exposures and breast health were collected using electronic questionnaires
on the Research Electronic Data Capture (REDCap) and Salesforce platforms. The REDCap electronic
data capture tool was hosted at the University of California, Irvine and is a secure, web-based application
designed to support data capture for research studies [31]. Salesforce is a secure, cloud-based customer
relationship management system which is also used for research questionnaire data collection [32].
Environmental exposure questions included those regarding participants’ residential history, frequency
of organic food consumption, frequency of dining out, smoking history, and hormone use history.
Organic eating behaviors were assessed with both a general question asking “Do you eat organic
food?” as well as food-group specific questions for fruit, vegetables, grains, meat, and dairy, with
response choices for each question being seldom or never, sometimes, often or always, and don’t
know or not sure. This question is consistent with previous studies of organic eating behaviors [33,34].
Food-group specific questions also included an option for “I do not eat the food” to account for
different dietary patterns. Organic food was defined in the questionnaire as food that is either labeled
United States Department of Agriculture (USDA) Organic, purchased locally from an organic farm,
grown without pesticides in a home garden, or raised on organic feed without hormones and without
antibiotics. Participants provided their current residential address, previous cities or ZIP codes, and
length of residence at each location. Geocoded addresses can be used to model residential exposure
to air pollution, as previously described in similar studies [22,35], or other neighborhood-specific
environmental factors, such as green space. Never-smokers were defined as those who had never
smoked regularly for 6 months or more. Questions regarding occupation and use of pesticides were
added to the questionnaire approximately midway through study enrollment (250 participants were
asked these questions). Breast health questions included those regarding the participant’s history of
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mammography screening, personal and family history of breast and other cancers, personal gynecologic
history, alcohol consumption, and physical activity. All questionnaires used branching logic, and
the full text of each question for all questionnaires is provided in Table S1. Given the strong association
between mammographic density and breast cancer risk [36,37] and its response to exposures such as
exogenous hormones [38] and BMI [39], mammographic density (BIRADS categories 1, 2, 3, and 4) was
also collected from participants’ most recent mammogram reports.
2.3.3. Dietary Data Collection and Processing
Participants were advised that during the 10-day period prior to their scheduled blood collection
appointment, they would be contacted by the study team on three days at 10:00 AM to ask them to
complete a 24-h dietary recall for the previous day. Contact was via text message or email according to
participant preference. Participants were not told which days they would be contacted, and requests
were made to include one weekend day, in order to capture their typical diet. Two recalls were
requested on the same days as requests for first-void urine samples so the data would be paired.
Dietary intake data for 24-h recalls were collected and analyzed using the Automated
Self-Administered 24-h (ASA24) Dietary Assessment Tool, version 2016, developed by the National
Cancer Institute (Bethesda, MD, USA) [40]. ASA24 is modeled on the USDA’s Automated Multiple-Pass
Method (AMPM) and collects data using a meal-based approach to evaluate the consumption of
specific food groups in addition to overall diet by calculating a dietary score [41] and is available in
Spanish. This assessment is able to provide high quality information regarding dietary intake at a low
cost with minimal participant burden [42].
Participants were also asked about their usual food consumption, including portion sizes, during
the previous 12 months using the Diet History Questionnaire (DHQ II), a freely available food frequency
questionnaire (FFQ) developed by the National Cancer Institute [43]. English speakers received the web
version of DHQ II and Spanish speakers received a paper version of the DHQ I since a paper version of
the DHQ II was not available in Spanish. DHQ I has been validated in three studies [44–46]. Updates
to the second version included additions of foods and supplements but were minimal such that
validation findings are unlikely to be significantly modified. Diet*Calc Software (V1.4.3, National
Cancer Institute, Bethesda, MD, USA) [47] was used to analyze the DHQ data and generate nutrient
and food group intake estimates. Dietary recalls which had total kcals lower than 500 kcal/day or
higher than 3500 kcal/day were removed, which are cutoffs commonly used to exclude outliers in diet
data for epidemiologic studies [48].
2.3.4. DNA Methylation Data Collection and Processing
Genomic DNA (1000 ng) samples were bisulfite converted using the Zymo EZ DNA methylation kit
(Zymo Research, Irvine, CA, USA) according to the manufacturer’s recommendations at the University
of Southern California Molecular Genomics Core Facility. Bisulfite-converted DNA was then used
as a substrate for the Illumina Infinium MethylationEPIC BeadChip (Illumina, San Diego, CA, USA),
which measures methylation levels at over 850,000 sites throughout the genome [49]. After assessing
sample quality using the standard controls included in the array, methylation array data were filtered
and normalized using the recommended pre-processing steps for Illumina methylation BeadChip
data [50].
2.3.5. Questionnaire Data Curation
Questionnaire data were reviewed and curated, and some variables were regrouped to improve
clarity and conciseness. For example, for race/ethnicity, only 5.0% of participants indicated
a race/ethnicity other than non-Hispanic white, Hispanic, or Asian. These participants were grouped
into the category “Other/Unknown” with those who indicated Unknown or left the field blank.
Occupations were classified into six groups based on the Standard Occupational Classification (SOC)
from the U.S. Department of Commerce, Office of Federal Statistical Policy and Standards, and O*NET,
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the U.S. Occupational Information Network [51,52]. Occupation classification was performed by
two separate individuals (W.-L.H. and D.F.), and any discrepancies were resolved by a third-party
adjudicator (H.L.P.). Participants’ mailing addresses were used to determine their current residences.
Cities within Orange County were classified into either North or South Orange County [53]. For
physical activity, participants were classified based on whether their weekly physical activity met
the Physical Activity Guidelines for Americans, issued by The Department of Health and Human
Services, which recommend at least 150 min per week of moderate-intensity aerobic activity, at least
75 min a week of vigorous-intensity aerobic activity, or an equivalent combination of moderate- and
vigorous- intensity aerobic activity for adults [54].
2.3.6. Statistical Analysis
Basic cohort characteristics were compared for the two recruitment methods (targeted and
community recruitment) using the student’s t-test for age and Fisher’s exact test for all other variables.
Fisher’s exact test was used rather than the chi-squared test due to small counts in some cells of
the contingency table, which may affect the precision of the chi-squared approximation.
3. Results
3.1. Specimen and Questionnaire Collection
Four hundred postmenopausal women aged 45 to 66 years enrolled in the study (Table 2).
All participants provided a blood sample and two urine samples. Over half of the participants
(n = 223, 55.8%) provided the optional saliva sample. Some urine samples and dietary recalls were not
completed on the days requested because participants forgot to complete them, were unexpectedly
out of town or unavailable, or due to temporary problems accessing the ASA24 system. In these
cases, participants were asked to complete their urine collection or dietary recall the next day that
was feasible. Some study appointments had to be rescheduled because participants due to illness
or other reasons. The average time between collection of the two urine samples was 2 days (SD 1.7,
range 1–17 days). The average time between collection of urine samples and blood samples was 3 days
(SD 3.3, range 0–26 days). DNA was extracted from buffy coat of all 400 participants’ blood samples
(mean 291.0 ± 140.4 µg DNA extracted, range 10.3–919.8 µg).
All participants completed the breast health questionnaire and environmental exposures
questionnaire. After excluding ASA24 dietary recalls with kcals outside of the range of 500 kcals to
3500 kcals, 379 participants (94.8%) had at least one dietary recall, and 67.5% of participants had all
three requested recalls (Table 2). Based on the study design, two dietary recalls for each participant
were intended to be paired with urine samples. 344 participants (86.0%) had at least one paired dietary
recall and 234 participants (58.5%) had both paired dietary recalls. 263 participants (65.8%) completed
the food frequency questionnaire. There were no significant differences in questionnaire completion
rates between participants from the two recruitment methods (data not shown).
Table 2. Cohort characteristics for the MEE Study.
Characteristic Mean (SD) or N (%)
Age, years, mean (SD) 56.7 (4.6)
Race/Ethnicity, N (%)
Non-Hispanic white 257 (64.3)
Hispanic 74 (18.5)
Asian 43 (10.8)
Other/Unknown 26 (6.5)
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Table 2. Cont.
Characteristic Mean (SD) or N (%)
Education, N (%)
High school graduate or less 34 (8.5)
Some college or technical school 87 (21.8)
College graduate or more 277 (69.3)
Missing 2 (0.5)
Occupation, N (%), out of 250
Unemployed or disabled 11 (4.4)
Homemaker 12 (4.8)
Retired 23 (9.2)
Employed (Full-time or Part-time) 204 (81.6)
Current residence, N (%)
Los Angeles County 27 (6.8)
North Orange County 185 (46.2)
South Orange County 178 (44.5)
Other 10 (2.6)
Diet questionnaires completed,
N (%)
ASA24 dietary recall
None 21 (5.3)
1 33 (8.3)
2 76 (19.0)
≥3 270 (67.5)
Paired urine and ASA dietary
recall *
None 56 (14)
1 110 (27.5)
2 234 (58.5)
Food frequency questionnaire 263 (65.8)
* A dietary recall was considered to be “paired” with a urine sample if the recall was provided for the day immediately
prior to the first-void urine sample.
3.2. Participant Demographics
Since this study had a specific recruiting age range, the average age of participants was 56.7 years
with small variation (SD 4.6 years). The majority of participants were non-Hispanic white (64.3%)
followed by Hispanic (18.5%), Asian (10.8%), and Other/Unknown (6.5%). Over 50% of participants
graduated from college or had more education. Of the participants who indicated their occupation
(N = 250), 81.6% were currently employed either full-time or part-time. 56.4% currently had an
occupation related to management, business, science or arts, followed by sales and office-related
occupations (15.2%) and service-related occupations (8.0%). Over 90% of participants lived in either
North or South Orange County. A small percentage of participants (9.4%) were from Los Angeles, San
Bernardino, Riverside and San Diego Counties (Table 2). There were no significant differences between
participants from the two recruitment methods for age, race/ethnicity, or education (data not shown).
3.3. Lifestyle and Health History
The majority of cohort participants were never-smokers (73.0%) (Table 3). Only 17 participants
(4.3%) currently smoked, while 90 participants (22.5%) previously smoked regularly. The majority of
cohort participants (68.0%) consumed less than two alcoholic drinks per week or never consume alcohol,
while 31.2% reported consuming two or more alcoholic drinks per week. Only 39.0% of participants
were meeting physical activity guidelines. The average body mass index (BMI) in the cohort was
26.8 kg/m2.
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Table 3. Lifestyle factors and health histories among study participants.
Characteristic Mean (SD) or N (%)
Smoking status, N (%)
Current smoker 17 (4.3)
Former smoker 90 (22.5)
Never-smoker 292 (73.0)
Missing 1 (0.3)
Alcohol consumption, N (%)
Never 106 (26.5)
Less than 2 drinks per week 166 (41.5)
2–7 drinks per week 74 (18.5)
More than 7 per week 51 (12.8)
Missing 3 (0.8)
Weekly physical activity meets the Physical Activity
Guidelines for Americans, N (%)
No 226 (56.5)
Yes 156 (39.0)
Missing 18 (4.5)
BMI, kg/m2, mean (SD) 26.8 (6.5)
Age of menarche, mean (SD) 12.8 (1.5)
Pregnancy history
Number of live births, N (%)
0 87 (21.8)
1 74 (18.5)
2 141 (35.3)
3 74 (18.5)
More than 3 24 (6.0)
Age at first birth, mean (SD) 27.7 (6.2)
Age of menopause, mean (SD) 48.7 (6.1)
History of gynecologic surgery, N (%)
Oophorectomy 84 (21.0)
Hysterectomy 99 (24.8)
Hormone replacement therapy use, N (%)
Never 255 (63.8)
Previous 62 (15.5)
Current 82 (20.5)
Missing 1 (0.3)
Mammographic breast density, N (%)
Almost entirely fatty 42 (10.5)
Scattered fibroglandular densities 110 (27.5)
Heterogeneously dense 163 (40.8)
Extremely dense 77 (19.3)
Missing 8 (2.0)
Family history of cancer in first-degree relatives, N (%)
Breast cancer (invasive or ductal carcinoma in situ [DCIS]) 83 (21.1)
Ovarian cancer 13 (3.3)
About 78% of participants had given birth at least once, with a mean age of 27.7 years old at first
birth. The average ages of menarche and menopause were 12.8 years and 48.7 years, respectively.
121 participants (30.3%) had either a hysterectomy or oophorectomy, with 62 (15.5%) having had
both surgeries. Just over 20% of participants had first-degree relatives who had been diagnosed with
breast cancer, while 3.3% had a first-degree family history of ovarian cancer. 60.0% of participants had
heterogeneously or extremely dense breasts according to their most recent mammogram. The most
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commonly reported personal health conditions were back pain (N = 84, 21.0%), thyroid disease
(N = 71, 17.8%), hypertension (N = 70, 17.5%), and depression (N = 50, 12.5%). Just over 10% (N = 44)
of participants reported a previous diagnosis of cancer (besides breast cancer). The most commonly
reported cancers were non-melanoma skin cancer (N = 10), melanoma (N = 9), cervical cancer (N = 7),
and thyroid cancer (N = 6). Five participants (1.3%) had previously been diagnosed with ovarian cancer.
3.4. Environmental Exposures
Participants were asked questions regarding environmental exposures through their daily activities;
responses are summarized in Table 4. Frequency of organic food consumption in the cohort was quite
evenly distributed, with 31.8% of participants reporting “often or always” eating organic food and
39.5% reporting “seldom or never” eating organic food. Over 90% of participants primarily drank
bottled or filtered water, while 9.0% drank tap water without a filter. Only 13.5% of participants had
ever lived on a farm; 5.5% had lived on a farm for more than 10 years. Of the participants who were
asked about their use of pesticides, 20.0% (N = 50 out of 250) reported using pesticides at home or
work within the past week.
Table 4. Environmental factors among study participants.
Characteristic Mean (SD) or N (%)
Organic food consumption frequency, N (%)
Often or always 127 (31.8)
Sometimes 114 (28.5)
Seldom or never 158 (39.5)
Missing 1 (0.3)
Source of drinking water, N (%)
Tap water (without filter) 36 (9.0)
Bottled water 158 (39.5)
Filtered water 204 (51.0)
Don’t know or not sure 1 (0.3)
Missing 1 (0.3)
History of living on a farm, N (%)
> 10 years 22 (5.5)
≤ 10 years 32 (8.0)
None 346 (86.5)
Age when started living on a farm, mean (SD) 8.8 (11.2)
Used pesticides at home or workplace within
past 7 days, N (%), out of 250
No 174 (69.6)
Yes 50 (20.0)
Don’t know or not sure 26 (10.4)
4. Discussion
Environmental exposures are ubiquitous in daily life and have been associated with a multitude of
diseases. However, many environmental exposures are difficult to objectively assess due to inaccurate
self-reported data or challenges with biomarker measurement [16]. The development of blood-based
biomarkers for environmental exposures will allow us to more accurately study the long-term impact
of these exposures by leveraging existing large cohort studies with banked blood and/or DNA
samples. We established the MEE Study in order to bridge this gap in knowledge by developing DNA
methylation-based biomarkers for environmental exposures and other risk factors for disease. Such
biomarkers have been identified for some exposures [18,22,25] but not for many others.
Our targeted approach to recruitment had a high success rate: 20.7% of all potential participants
who were contacted and 43.0% of those who responded to our initial contact attempts eventually
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completed the study. This is likely due to the targeted recruitment pool being members of a breast cancer
screening program who consented to being contacted for future research studies. Of the women who
were eligible for the study, the most common reasons given for declining to participate were that they
were uninterested, had concerns about the time commitment involved, and had concerns about using
a computer or mobile phone to complete study questionnaires. Because the community recruitment
method relied on participants initiating contact with the study team, it is impossible to know the success
rate or reasons for non-participation in this group. However, the general demographics of participants
recruited through each method were largely similar (data not shown).
A primary strength of our study is the resulting biorepository of plasma, serum, urine, and
saliva as well as extracted DNA from the buffy coat. Plasma and serum can be analyzed for an array
of molecules including antibodies and other proteins, antigens, lipids, hormones, and exogenous
substances. Multiple urine samples allow for the reasonably representative measurement of chemicals
with short half-lives. However, the relatively short time period of biospecimen collection (up to
10 days between urine samples) remains a limitation of the study. Certain exposures of interest are
likely to be relatively consistent over time, while others may exhibit strong temporal variability. We
plan to leverage the MEE Study population in the future by recruiting a subset of cohort members to
a longitudinal study, providing repeated biospecimens which will assess environmental exposures
over a longer period of time. While analyses of urinary glyphosate, organophosphates, and bisphenols
have been completed, remaining aliquots of stored urine samples are available for analysis of other
environmental chemicals as well as metabolomic and electrolyte analysis. Some of the extracted blood
DNA has been used for DNA methylation array analysis, and remaining blood DNA can be used for
other genetic and epigenetic analyses. Stored saliva samples can also be used for genetic and epigenetic
analyses as well as microbiome or biochemical analyses in the future.
Another strength is our comprehensive study data which includes detailed dietary information
(multiple 24-h dietary recalls and a food frequency questionnaire), self-reported environmental
exposures, lifestyle factors, residential history, occupation, and personal and family health history,
especially breast health-related data. While our sample size is much smaller than large cohort studies
such as the Women’s Health Initiative or Nurses’ Health Study, this smaller sample size allowed deep,
focused characterization of each participant with omics-scale data from diverse biospecimens (blood,
saliva, and urine). This data was used to prepare a nutrition and environmental exposure report for
return to study participants, and 99% of participants requested to receive the reports. Dietary recalls
and first-void urine samples were unannounced, which should provide a more unbiased assessment of
usual diet and exposures. Two dietary recalls were paired with urine samples; that is, participants
received a request at 7:30 PM one evening to collect their first-void urine the next day, followed by
a second message at 10:00 AM to request that they complete a 24-h dietary recall reflecting the previous
day’s intake. Participants were not informed at the time of recruitment that urine samples and dietary
recalls would be paired, so the request for a urine sample should not have affected the unannounced
nature of the dietary recall. In addition, because the urine sample request was sent at 7:30 PM, most
of that day’s dietary intake would have already taken place, further reducing the chance of bias.
Additionally, participants provided information on their current and former residences, which may be
used in the future to assess residential exposure to air pollution as well as other neighborhood factors.
However, due to the questionnaire-based assessment of most environmental exposures, in order to
minimize participant burden, not all exposures were captured.
A major limitation of the MEE Study is the lack of follow-up and thus health outcome data.
The study was originally conceived with a cross-sectional design to allow the development of exposure
biomarkers, which does not require health outcome data. This limitation does not affect the primary
goal to identify epigenetic markers of environmental exposures, which will support future studies of
potential relationships between environmental exposures and health. However, the MEE Study cohort
is well-characterized and its participants have shown a high willingness to participate in research.
Thus, the data collected can be enhanced in the future through linkage to national and state-level cancer
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registries, Department of Motor Vehicles and voter registration records, hospital discharge records
from the California Office of Statewide Health Planning and Development (OSHPD), mortality records,
and other sources of data. Additional data may also be gathered through follow-up questionnaires.
The study cohort was drawn from the primarily suburban area of Orange County, California.
Similar to the demographic characteristics of the region, study participants are fairly racially/ethnically
diverse with a large proportion being of Asian and Hispanic heritage, and are largely college
educated [55]. Generally, the study population exhibited higher levels of healthful behaviors than
the general U.S. population. For example, just 4.3% of study participants were current smokers
compared to 19.7% of women aged 45–64 nationwide; similarly, 22.3% of study participants had a BMI
of 30 kg/m2 or greater, compared to 32.4% of women aged 45–64 nationwide [56]. An exception was
the adherence to physical activity guidelines: 39.0% of participants met these guidelines compared
to 40.9% of women aged 45-64 nationwide [56]. Since Orange County has a large Spanish-speaking
population [55], study materials were translated to Spanish; eighteen study participants (4.5%)
requested Spanish-language materials and communication. Additionally, the study population is
entirely composed of postmenopausal women, which minimizes the biological variance in DNA
methylation and other markers due to age, sex, or menopausal status, but may limit the generalizability
of the results. Applicability of future study results will need to be validated in other populations.
5. Conclusions
The Markers for Environmental Exposures (MEE) Study is a well-characterized cohort of
400 postmenopausal women residing in Southern California. In addition to comprehensive exposure,
dietary, and health history data, the study established a biorepository of blood, urine, and saliva
samples. The long-term aims of the study are to (1) identify biomarkers, especially epigenetic markers,
of environmental exposures, such as pesticides, air/food/water contaminants, and industrial chemicals
that are commonly encountered in the general population; and (2) support the study of potential
relationships between environmental exposures and health and health-related factors. While studies
have been initiated to identify DNA methylation markers for some environmental exposures by
the study investigators, the MEE Study is also intended to serve as a resource for researchers beyond
the original investigators.
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